Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Nov 1:192:74-79.
doi: 10.1016/j.drugalcdep.2018.07.034. Epub 2018 Sep 12.

Hepatitis C virus prevalence and estimated incidence among new injectors during the opioid epidemic in New York City, 2000-2017: Protective effects of non-injecting drug use

Don C Des Jarlais  1 , K Arasteh  2 , J Feelemyer  2 , C McKnight  2 , David M Barnes  2 , David C Perlman  2 , A Uuskula  3 , H L F Cooper  4 , Susan Tross  5
Affiliations

Hepatitis C virus prevalence and estimated incidence among new injectors during the opioid epidemic in New York City, 2000-2017: Protective effects of non-injecting drug use

Don C Des Jarlais et al. Drug Alcohol Depend. .

Abstract

Objective: Assess hepatitis C virus (HCV) prevalence and incidence among person who began injecting drugs during the opioid epidemic in New York City (NYC) and identify possible new directions for reducing HCV infection among persons who inject drugs.

Methods: 846 persons who began injecting drugs between 2000 and 2017 were recruited from persons entering Mount Sinai Beth Israel substance use treatment programs. A structured interview was administered and HCV antibody testing conducted. Protective effects of non-injecting drug use were examined among persons who "reversed transitioned" to non-injecting drug use and persons who used non-injected heroin in addition to injecting.

Results: Participants were 79% male, 41% White, 15% African-American, 40% Latinx, with a mean age of 35. Of those who began injecting in 2000 or later, 97 persons (11%) "reverse transitioned" back to non-injecting drug use. Reverse transitioning was strongly associated with lower HCV seroprevalence (30% versus 47% among those who continued injecting, p < 0.005). Among those who continued injecting, HCV seropositivity was inversely associated with current non-injecting heroin use (AOR = 0.72, 95%CI 0.52-0.99). HCV incidence among persons continuing to inject was estimated as 13/100 person-years. HCV seropositive persons currently injecting cocaine were particularly likely to report behavior likely to transmit HCV.

Conclusions: Similar to other locations in the US, NYC is experiencing high rates of HCV infection among persons who have begun injecting since 2000. New interventions that facilitate substitution of non-injecting for injecting drug use and that reduce transmission behavior among HCV seropositives may provide additional methods for reducing HCV transmission.

Keywords: HIV; Hepatitis C; Opioid epidemic; Persons who inject drugs.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest

No conflict declared.

References

    1. Centers for Disease Control and Prevention, 2018. U.S. drug overdose deaths continue to rise; increase fueled by synthetic opioids Retrieved from https://www.cdc.gov/media/releases/2018/p0329-drug-overdose-deaths.html.
    1. Cerdá M, Gaidus A, Keyes KM, Ponicki W, Martins S, Galea S, Gruenewald P, 2017. Prescription opioid poisoning across urban and rural areas: Identifying vulnerable groups and geographic areas. Addiction 112, 103–112. - PMC - PubMed
    1. Deren S, Kang S-Y, Colón HM, Robles RR, 2007. The Puerto Rico–New York airbridge for drug users: Description and relationship to HIV risk behaviors. J. Urban Health 84, 243–254. - PMC - PubMed
    1. Des Jarlais DC, Cooper H, Arasteh K, Feelemyer J, McKnight C, Ross Z, 2018. Potential geographic “hotspots” for drug-injection related transmission of HIV and HCV and for initiation into injecting drug use in New York City, 2011–2015, with implications for the current opioid epidemic in the US. PLoS One 13, e0194799. - PMC - PubMed
    1. Des Jarlais DC, Arasteh A, Hagan H, McKnight C, Perlman D, Friedman S, 2009. Persistence and change in disparities in HIV infection among injecting drug users in New York City after large-scale syringe exchange. Am. J. Public Health 99, S445–S451. - PMC - PubMed

Publication types

MeSH terms